These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 11877243

  • 1. [A study of Na(+)-K(+)-ATP ase activity in erythrocyte membrane from diabetic retinopathy patients].
    He J, Qiu Y, Zhou X.
    Zhonghua Yan Ke Za Zhi; 1998 Nov; 34(6):421-3. PubMed ID: 11877243
    [Abstract] [Full Text] [Related]

  • 2. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
    Raccah D, Gallice P, Pouget J, Vague P.
    Diabete Metab; 1992 Nov; 18(3):236-41. PubMed ID: 1327887
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
    Djemli-Shipkolye A, Gallice P, Coste T, Jannot MF, Tsimaratos M, Raccah D, Vague P.
    Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Abnormal erythrocyte Na, K-ATPase activity in a northeastern Thai population.
    Tosukhowong P, Chotikasatit C, Tungsanga K, Sriboonlue P, Prasongwattana V, Pansin P, Sitprija V.
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23(3):526-30. PubMed ID: 1336901
    [Abstract] [Full Text] [Related]

  • 9. Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.
    Shahid SM, Mahboob T.
    Pak J Pharm Sci; 2008 Apr; 21(2):172-9. PubMed ID: 18390448
    [Abstract] [Full Text] [Related]

  • 10. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M.
    Exp Diabesity Res; 2004 Apr; 5(1):37-50. PubMed ID: 15198370
    [Abstract] [Full Text] [Related]

  • 11. Transmembrane cationic fluxes in erythrocytes of diabetics and normal men.
    Lijnen P, Fenyvesi A.
    Methods Find Exp Clin Pharmacol; 1994 Apr; 16(1):37-47. PubMed ID: 8164472
    [Abstract] [Full Text] [Related]

  • 12. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
    Forst T, De La Tour DD, Kunt T, Pfützner A, Goitom K, Pohlmann T, Schneider S, Johansson BL, Wahren J, Löbig M, Engelbach M, Beyer J, Vague P.
    Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
    [Abstract] [Full Text] [Related]

  • 13. [Determination of human erythrocyte membrane Na+/K(+)-ATPase activity in small volume of blood sample].
    Teraoka K, Miyagoshi M, Fujikawa K, Odajima S, Sugita T, Asaji T, Matsui S, Tsuritani I, Honda R, Yamada Y.
    Rinsho Byori; 1992 Apr; 40(4):410-6. PubMed ID: 1317473
    [Abstract] [Full Text] [Related]

  • 14. Reduced Na(+), K(+)-ATPase activity in erythrocyte membranes from patients with phenylketonuria.
    Bedin M, Estrella CH, Ponzi D, Duarte DV, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM.
    Pediatr Res; 2001 Jul; 50(1):56-60. PubMed ID: 11420419
    [Abstract] [Full Text] [Related]

  • 15. Effects of oxidative stress on the erythrocyte Na+,K+ ATPase activity in female hyperthyroid patients.
    Konukoglu D, Yelke HK, Hatemi H, Sabuncu T.
    J Toxicol Environ Health A; 2001 Jun 22; 63(4):289-95. PubMed ID: 11437061
    [Abstract] [Full Text] [Related]

  • 16. [The effect of carnosine on the activity of Na,K,ATPase: prospective uses in clinical cardiology].
    Snimoniia GV, Tatishvili NI, Shiliia DSh, Bakanidze NT, Khachidze MV.
    Biokhimiia; 1992 Sep 22; 57(9):1343-7. PubMed ID: 1334706
    [Abstract] [Full Text] [Related]

  • 17. [Changes of erythrocyte membrane ATPase activities and plasma lipids in patients with coronary heart disease].
    Lu G, Ouyang S, Pei Z.
    Hunan Yi Ke Da Xue Xue Bao; 1999 Sep 22; 24(1):68-70. PubMed ID: 11938746
    [Abstract] [Full Text] [Related]

  • 18. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
    Maslova MN, Ogorodnikova LE, Titkov IuS.
    Fiziol Zh SSSR Im I M Sechenova; 1991 Sep 22; 77(9):232-7. PubMed ID: 1666609
    [Abstract] [Full Text] [Related]

  • 19. [Alcohol-related high blood pressure, and erythrocyte Na+/K(+)-ATPase activity, sodium and potassium concentrations].
    Tsuritani I, Teraoka K, Miyagoshi M, Honda R, Ishizaki M, Yamada Y.
    Rinsho Byori; 1993 Dec 22; 41(12):1353-7. PubMed ID: 8295347
    [Abstract] [Full Text] [Related]

  • 20. Effects of C-peptide on microvascular blood flow and blood hemorheology.
    Forst T, Kunt T.
    Exp Diabesity Res; 2004 Dec 22; 5(1):51-64. PubMed ID: 15198371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.